OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $79,000 | -75.3% | 184,487 | -67.5% | 0.00% | – |
| Q1 2016 | $320,000 | -67.1% | 567,254 | +0.4% | 0.00% | – |
| Q4 2015 | $972,000 | -12.2% | 565,174 | +7.7% | 0.00% | – |
| Q3 2015 | $1,107,000 | -69.8% | 524,771 | -29.1% | 0.00% | -100.0% |
| Q2 2015 | $3,662,000 | -41.1% | 739,855 | -6.9% | 0.00% | -50.0% |
| Q1 2015 | $6,219,000 | +33.7% | 794,302 | +3.5% | 0.00% | +100.0% |
| Q4 2014 | $4,650,000 | +46.4% | 767,292 | +2.9% | 0.00% | 0.0% |
| Q3 2014 | $3,177,000 | -60.9% | 745,616 | -43.3% | 0.00% | 0.0% |
| Q2 2014 | $8,128,000 | +115.2% | 1,315,064 | +126.3% | 0.00% | 0.0% |
| Q1 2014 | $3,777,000 | +36.1% | 581,032 | +17.9% | 0.00% | 0.0% |
| Q4 2013 | $2,776,000 | -60.3% | 493,019 | -56.8% | 0.00% | 0.0% |
| Q3 2013 | $6,988,000 | +143.4% | 1,140,032 | +132.1% | 0.00% | 0.0% |
| Q2 2013 | $2,871,000 | – | 491,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |